Clinical trial
A Randomized, Double-blind, Crossover Study to Assess the Relative Bioavailability of Two Coenzyme Q10 Products in Men and Women
NCT07530250 is registered in ClinicalTrials.gov with Midwest Center for Metabolic and Cardiovascular Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Crossover Study to Assess the Relative Bioavailability of Two Coenzyme Q10 Products in Men and Women
- Lead sponsor
- Midwest Center for Metabolic and Cardiovascular Research
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 18, 2026
- Completion date
- July 1, 2026
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coq10 blood levels